To achieve capital growth through investing in high growth, development stage biotechnology companies.
Find out MoreInt.biotech. Share Price | |
---|---|
Price | 642.00 |
Bid | 640.00 |
Ask | 642.00 |
Change | 0.00 (0.00%) |
Volume | 42,016 |
Open | 638.00 |
High | 642.00 |
Low | 638.00 |
Prev. Close | 642.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 37.62m |
Market Capitalisation | £241.51m |
Market Size | 750 |
52 Week High | 704.00 |
52 Week High Date | 28-Feb-2024 |
52 Week Low | 548.00 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 47 |
---|---|
Vol. Sold | 34,630 |
Sold Value | £221.18k |
Vol. Bought | 7,386 |
Bought Value | £47.28k |
PE Ratio | 38.23705 |
Earnings | 16.79 |
Dividend | 28.20 |
Yield | 4.393% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
17-May-24 | 16:37:32 | 642.00 | 5,495 | Sell* | 640.00 | 642.00 | 35.28k | O Ordinary |
17-May-24 | 16:35:28 | 642.00 | 286 | Buy* | 640.00 | 642.00 | 1,836 | UT Uncrossing Trade |
17-May-24 | 16:21:32 | 640.02 | 1,000 | Sell* | 640.00 | 642.00 | 6,400 | O Ordinary |
17-May-24 | 16:21:13 | 641.47 | 1,000 | Buy* | 640.00 | 642.00 | 6,415 | O Ordinary |
17-May-24 | 16:07:58 | 640.00 | 565 | Buy* | 632.00 | 642.00 | 3,616 | A Automatic Execution |
17-May-24 | 16:07:58 | 640.00 | 35 | Sell* | 640.00 | 642.00 | 224.00 | A Automatic Execution |
17-May-24 | 16:04:13 | 641.47 | 135 | Buy* | 640.00 | 642.00 | 865.98 | O Ordinary |
17-May-24 | 15:56:49 | 640.00 | 3,905 | Sell* | 640.00 | 642.00 | 24.99k | O Ordinary |
17-May-24 | 15:49:27 | 640.00 | 300 | Sell* | 640.00 | 642.00 | 1,920 | A Automatic Execution |
17-May-24 | 15:49:04 | 640.00 | 600 | Sell* | 640.00 | 642.00 | 3,840 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Nov-23 | 07-Nov-23 | Buy | Caroline Gulliver held the position of Independent Non-Executive Director at the time of this trade.Caroline Gulliver | 573.15 | GBX | 2,500 | 17,000 |
04-Aug-23 | 03-Aug-23 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 632.00 | GBX | 1,500 | 11,500 |
03-Aug-23 | 03-Aug-23 | Buy | Katherine Cornish-Bowden held the position of Senior Independent Director at the time of this trade.Katherine Cornish-Bowden | 633.18 | GBX | 1,500 | 12,500 |
11-May-22 | 11-May-22 | Buy | Patrick Maxwell held the position of Independent Non-Executive Director at the time of this trade.Patrick Maxwell | 589.35 | GBX | 3,725 | 3,725 |
01-Apr-22 | 01-Apr-22 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 633.00 | GBX | 2,500 | 10,000 |